Concomitant inpatient prescribing of strong opioids with sedatives: Associations with comorbid conditions
Abstract Co‐prescribing of opioids and sedatives is a known risk factor for opioid‐induced ventilatory impairment (OIVI). Prevalence data for sedative and opioid co‐prescription in inpatients in Australia are unknown. Our objective was to determine the prevalence of inpatient sedative and opioid co‐...
Main Authors: | Ray J. Li, Gillian E. Caughey, Sepehr Shakib |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.717 |
Similar Items
-
“We don’t want to sedate him” - A qualitative interview study on intentions when administering sedative drugs at the end of life in nursing homes and hospitals
by: Sophie Meesters, et al.
Published: (2021-09-01) -
Variables Influencing the Depth of Conscious Sedation in Plastic Surgery: A Prospective Study
by: Hyeonjung Yeo, et al.
Published: (2017-01-01) -
Opioid and/or Psychotropic Use Increases Intraprocedural Sedation Drug Requirements
by: Sreeja Sanampudi, et al.
Published: (2021-05-01) -
The Sleeping Pill Prescription Rate for Inpatients at a General Hospital
by: Soyoung Youn, et al.
Published: (2016-06-01) -
Hypnotics use in children 0–18 months: moderate agreement between mother-reported survey data and prescription registry data
by: Ingvild Holdø, et al.
Published: (2017-09-01)